In proliferative tumor and leukemia cells, it was also found that phosphorylated VEGFR2 has a nuclear expression [8], [9], [10], [11], [12], suggesting that molecular mechanisms that contribute to tumor angiogenesis might require a specific activity of this protein in the nucleus. Here, KDR is linked to neoplasm.